chapter
focu
inform
regard
smallpox
smallpox
vaccin
sinc
notabl
persist
threat
smallpox
bioterrorist
agent
intern
prepared
smallpox
outbreak
vaccin
advers
event
issu
includ
myopericard
second
thirdgener
smallpox
vaccin
hivaid
issu
similar
microbi
threat
monkeypox
sar
exampl
hospit
citi
smallpox
prepared
effort
begin
late
recent
review
us
other
includ
center
diseas
control
prevent
cdc
world
health
organ
address
histori
clinic
featur
pathogenesi
prevent
diagnosi
manag
smallpox
addit
refer
also
made
classic
comprehens
text
smallpox
terrorist
airplan
hijack
attack
septemb
subsequ
anthrax
bioterror
attack
addit
intern
effort
undertaken
reassess
threat
smallpox
reintroduc
human
popul
quarter
centuri
erad
effort
includ
focus
recognit
clinic
aspect
smallpox
public
health
respons
smallpox
vaccin
need
expand
smallpox
vaccin
stockpil
unit
state
cdc
depart
defens
dod
initi
extens
educ
train
regard
smallpox
smallpox
vaccin
accord
cdc
januari
begin
civilian
vaccin
program
octob
least
civilian
vaccin
smallpox
civilian
program
declin
summer
tempor
link
three
event
began
march
unexpect
find
myopericard
small
percentag
vaccine
grow
appreci
risk
vaccin
appar
absenc
biolog
weapon
iraq
confirm
subsequ
invas
dod
decemb
octob
smallpox
vaccin
administ
wwwsmallpoxarmymileventspsafetysumasp
unlik
civilian
program
dod
smallpox
vaccin
program
continu
without
paus
fact
expand
latter
half
june
memorandum
pentagon
deputi
secretari
defens
direct
expans
vaccin
program
militari
smallpox
anthrax
expans
vaccin
includ
uniform
dod
personnel
serv
central
command
area
respons
includ
central
asia
part
east
africa
korean
peninsula
area
consid
special
risk
militari
personnel
wwwsmallpoxarmymilresourcespoliciesasp
alibek
conclud
paper
discuss
genet
modifi
variola
viru
design
enhanc
effect
weapon
mass
destruct
scenario
build
work
publish
australia
involv
mousepox
ectromelia
gene
insert
interleukin
il
cytokin
weaken
cellmedi
immun
respons
virus
orthopoxvirus
inhibit
cytotox
tcell
interferon
ifn
product
clinic
mice
infect
mousepox
increas
mortal
significantli
decreas
protect
mousepox
prior
vaccin
similar
laboratori
work
variola
viru
insert
gene
relat
cytokin
perform
approv
futur
experi
given
risk
find
might
similar
howev
vaccinia
viru
studi
recent
mous
model
experi
report
nih
research
otherwis
fatal
challeng
vaccinia
viru
modifi
express
murin
could
prevent
prior
immun
nonrepl
attenu
vaccinia
viru
modifi
vaccinia
ankara
mva
import
find
vaccinia
viru
without
express
infect
human
well
mice
wherea
mousepox
viru
infect
human
addit
research
appli
immunolog
model
type
cytokin
type
cytokin
mousepox
vaccinia
studi
mice
infer
human
condit
atop
dermat
immunocompromis
diseas
pregnanc
could
lead
rational
novel
immunolog
therapi
orthopoxvirus
includ
vaccinia
variola
paper
publish
australia
mousepox
ectromelia
infect
virusresist
mice
result
product
strong
cytotox
tcell
cellular
immun
respons
contrast
mousepox
infect
suscept
mice
balbc
aj
result
littl
instead
result
product
delet
gene
chang
diseas
suscept
mice
loss
function
resist
mice
lead
mortal
similar
earlier
studi
australia
japan
found
mousepoxsuscept
mice
balbc
made
less
suscept
signal
transduc
activ
transcript
intracellular
signal
molecul
delet
common
theme
studi
strong
respons
exemplifi
need
prevent
decreas
mousepox
diseas
sinc
type
cytokin
crossinhibitori
impair
may
least
import
enhanc
strong
cellular
immun
respons
control
type
cytokin
may
critic
predomin
antibodi
immun
respons
control
type
cytokin
particularli
true
respons
directli
associ
weak
cellmedi
immun
respons
evidenc
impair
cytotox
tcell
product
earli
report
antivir
activ
vaccinia
extend
type
cytokin
model
human
situat
often
less
clear
cut
mice
data
support
view
atop
dermat
immunocompromis
diseas
hivaid
malign
even
normal
human
pregnanc
character
rel
decreas
normal
ratio
type
cytokin
type
cytokin
condit
associ
rel
decreas
cellmedi
immun
respons
addit
associ
increas
risk
advers
event
due
smallpox
vaccin
vaccinia
observ
import
control
orthopoxvirus
could
gener
hypothesi
subcutan
alreadi
fda
licens
sinc
chronic
granulomat
diseas
specif
medic
condit
could
benefici
control
lifethreaten
advers
effect
smallpox
vaccin
includ
progress
vaccinia
specif
rare
case
progress
vaccinia
respond
vaccinia
immun
globulin
vig
surgic
therapi
resect
consid
along
vig
subcutan
could
administ
investig
new
drug
ind
protocol
one
avail
success
clinic
set
use
would
avoid
surgic
resect
vaccinia
viru
viru
found
smallpox
vaccin
variola
viru
caus
agent
smallpox
two
distinct
virus
tabl
compar
two
relat
orthopoxvirus
rout
transmiss
system
interact
potenti
therapi
vaccinia
viru
never
caus
smallpox
vaccinia
viru
spread
via
respiratori
droplet
therefor
respiratori
precaut
need
person
vaccin
vaccinia
seriou
vaccin
reaction
treat
vig
wherea
smallpox
diseas
due
variola
viru
respons
vig
intraven
formul
vig
replac
older
intramuscular
formul
im
approv
fda
februari
fdalicens
antivir
drug
prevent
treat
ill
due
either
vaccinia
viru
variola
viru
tabl
list
way
smallpox
vaccin
differ
fdalicens
vaccin
includ
routin
use
bifurc
needl
fig
success
vaccin
take
document
skin
day
fig
variola
viru
transmit
multipl
way
far
common
via
respiratori
droplet
transmiss
fomit
cloth
bed
linen
occur
transmiss
aerosol
involv
droplet
nuclei
rare
occasion
document
hospit
mesched
germani
incub
period
variola
viru
mean
day
febril
prodrom
begin
headach
backach
nausea
prostrat
tabl
specul
incub
period
may
shorter
highli
virul
highdos
exposur
smallpox
accomplish
aerosol
releas
bioweapon
day
febril
prodrom
rash
begin
oral
mucosa
skin
typic
rash
concentr
centrifug
includ
face
palm
sole
infect
prior
clearcut
onset
rash
rare
highest
degre
infect
occur
rash
present
prior
case
myocard
andor
pericard
smallpox
vaccin
seldom
report
unit
state
report
europ
especi
scandinavia
australia
one
possibl
explan
use
differ
vaccinia
strain
unit
state
new
york
citi
board
health
strain
use
europ
australia
studi
militari
conscript
finland
routin
vaccin
smallpox
incid
symptomat
myocard
smallpox
vaccin
approxim
figur
base
case
myocard
occur
day
vaccin
without
etiolog
myocard
found
investig
unit
state
initi
report
myopericard
smallpox
vaccin
appear
march
trigger
immedi
investig
cdc
dod
investig
ongo
assess
causal
new
safeguard
implement
avoid
vaccin
person
histori
either
cardiac
diseas
stroke
three
risk
factor
present
tabl
tradit
risk
factor
heart
diseas
includ
high
blood
pressur
elev
cholesterol
diabet
smoke
posit
famili
histori
heart
diseas
age
year
octob
dod
diagnos
case
myopericard
vaccine
primari
vaccine
vaccine
cdc
identifi
probabl
suspect
case
myopericard
smallpox
vaccin
dod
publish
initi
find
june
two
updat
articl
well
dod
websit
dedic
smallpox
vaccin
program
wwwsmallpoxarmymileventspsafetysumasp
causal
relationship
accept
myopericard
part
common
dod
primari
vaccin
revaccin
occurr
within
day
vaccin
absenc
etiolog
dod
report
statist
signific
associ
develop
myopericard
male
white
among
primari
vaccine
significantli
increas
risk
myopericardit
within
day
smallpox
vaccin
observ
incid
contrast
dod
found
increas
risk
myopericard
revaccine
death
occur
prognosi
good
full
recoveri
vaccineassoci
myopericard
dod
report
initi
patient
normal
function
statu
echocardiographi
ekg
grade
exercis
test
mean
week
followup
atyp
nonlimit
persist
chest
discomfort
report
patient
causal
relationship
found
myocardi
infarct
ischem
event
smallpox
vaccin
likewis
retrospect
analysi
cardiac
death
mass
vaccin
program
approxim
million
person
new
york
citi
reveal
evid
increas
cardiac
death
among
advers
event
follow
vaccin
dod
report
octob
one
death
may
attribut
smallpox
vaccin
although
result
inconclus
accord
two
independ
civilian
physician
panel
patient
reservist
receiv
five
vaccin
includ
smallpox
vaccin
time
develop
lupuslik
ill
prior
death
day
five
vaccin
wwwsmallpoxmileventpanelreportasp
six
death
vaccin
judg
clearli
unrel
vaccin
sixteen
case
ischem
heart
diseas
angina
myocardi
infarct
occur
within
week
smallpox
vaccin
vaccine
case
judg
similar
normal
occur
among
unvaccin
militari
personnel
similar
age
octob
summari
wwwsmallpoxmileventpanelreportasp
forti
case
gener
vaccinia
report
treat
outpati
case
contact
vaccinia
found
nearli
spous
adult
intim
contact
outsid
workplac
importantli
case
vaccinia
transmiss
occur
vaccin
healthcar
worker
hcw
patient
cowork
neither
progress
vaccinia
eczema
vaccinatum
case
observ
militari
civilian
vaccine
wwwsmallpoxarmymileventspsafetysumasp
similarli
episod
vaccinia
transmiss
civilian
healthcar
worker
patient
cowork
dod
report
initi
patient
receiv
smallpox
vaccin
sinc
decemb
also
undiagnos
infect
human
immunodefici
viru
hiv
person
normal
major
reaction
vaccin
normal
heal
importantli
howev
none
person
aidsdefin
count
cellsul
opportunist
infect
malign
count
rang
cellsul
addit
patient
previous
vaccin
smallpox
one
patient
hiv
infect
report
seriou
nonfat
advers
event
receiv
standard
smallpox
vaccin
occur
us
armi
prior
avail
hiv
antibodi
test
time
smallpox
vaccin
still
routin
administ
militari
due
concern
potenti
use
smallpox
viru
bioweapon
soon
smallpox
vaccin
first
armi
recruit
patient
present
aidsdefin
cryptococc
mening
oral
candidiasi
tcell
count
cellsul
four
week
vaccin
hospit
mening
cm
cm
ulcer
develop
vaccin
site
next
day
pustular
lesion
appear
posterior
leg
buttock
lesion
also
ulcer
vaccinia
viru
cultur
lesion
weekli
intramuscular
treatment
vig
skin
lesion
complet
resolv
case
report
publish
accompani
editori
halsey
henderson
comment
sever
hundr
hivinfect
militari
recruit
must
receiv
multipl
immun
includ
vaccinia
without
complic
prior
mandatori
hivantibodi
test
exclus
hivposit
recruit
although
instanc
complic
smallpox
vaccin
patient
hiv
infect
report
use
recombin
vaccinia
express
hiv
protein
investig
form
cell
immunotherapi
rais
concern
vaccinia
viru
potenti
contribut
death
three
patient
aid
tcell
count
cellsul
phase
trial
pari
accord
zaguri
earlier
clinic
trial
cliniqu
universitair
kinshasa
democrat
republ
congo
pari
shown
similar
toxic
particular
hiv
cell
immunotherapi
use
paraformaldehyd
inactiv
recombin
vaccinia
express
hiv
protein
autolog
ebvtransform
bcell
review
decis
made
discontinu
use
sinc
concern
regard
complic
smallpox
vaccin
smallpox
infect
person
immunocompromis
condit
hivaid
transplant
discuss
bartlett
other
issu
regard
hivaid
smallpox
smallpox
vaccin
present
intern
aid
confer
barcelona
spain
event
smallpox
attack
possibl
exposur
possibl
rapid
test
hiv
infect
consid
possibl
screen
tool
howev
critic
point
person
expos
smallpox
contraind
vaccin
vaccinia
includ
hiv
infect
one
rapid
test
hiv
antibodi
use
fingerstick
specimen
call
oraquick
rapid
antibodi
test
approv
fda
novemb
fda
later
approv
oraquick
test
use
routin
whole
blood
venipunctur
sampl
septemb
fda
revis
time
result
test
would
interpret
min
would
ongo
global
hivaid
pandem
impact
global
public
health
respons
smallpox
reenter
human
popul
bioterrorist
weapon
potenti
public
health
societ
econom
implic
term
tri
contain
control
smallpox
set
especi
part
world
highest
preval
hiv
infect
subsaharan
africa
india
debat
view
alarm
potenti
dual
infect
hiv
variola
vaccinia
other
doubt
would
pose
insuper
problem
safer
smallpox
vaccin
need
thirdgener
smallpox
vaccin
use
attenu
vaccinia
virus
mva
strain
use
smallpox
vaccin
licens
japan
reevalu
option
immunocompromis
patient
event
smallpox
attack
immunocompromis
anim
model
studi
rhesu
macaqu
infect
simian
immunodefici
viru
siv
sivhiv
hybrid
viru
vaccin
attenu
replicationdefici
vaccinia
andor
standard
nonattenu
firstgener
dryvax
vaccin
give
attenu
vaccinia
vaccin
first
follow
dryvax
decreas
advers
event
seen
dryvax
alon
given
global
suscept
smallpox
sinc
erad
year
ago
subsequ
cessat
routin
vaccin
threat
smallpox
reintroduc
act
bioterror
make
insuffici
amount
smallpox
vaccin
nation
world
today
particularli
concern
reason
evid
destruct
stock
smallpox
viru
call
use
bioterror
weapon
character
crime
human
one
sever
recommend
intern
measur
prevent
return
smallpox
rare
highli
fatal
form
smallpox
known
hemorrhag
smallpox
deserv
specif
consider
due
strike
rapidli
progress
clinic
ill
specul
terrorist
would
attempt
smallpox
attack
caus
high
incid
hemorrhag
smallpox
strain
variola
abl
identifi
time
strain
variola
report
reproduc
caus
hemorrhag
smallpox
earli
form
hemorrhag
smallpox
found
rao
report
patient
much
shorten
time
mean
day
onset
smallpox
febril
prodrom
death
aerosol
attack
smallpox
occur
ten
thousand
person
infect
index
case
may
patient
earli
hemorrhag
smallpox
recognit
rare
manifest
smallpox
would
critic
trigger
immedi
public
health
respons
smallpox
outbreak
monkey
model
hemorrhag
smallpox
develop
cdc
us
armi
research
highdos
intraven
challeng
variola
viru
caus
hemorrhag
form
smallpox
monocyteassoci
viremia
analysi
immun
respons
anim
suggest
mark
impair
tumor
necrosi
factor
alpha
respons
express
transcript
factor
nfkb
anim
cidofovir
confer
prophylact
protect
hemorrhag
smallpox
find
author
attribut
overwhelm
natur
hemorrhag
smallpox
lethal
mean
time
death
day
highlevel
viremia
variola
associ
hemorrhag
smallpox
abovement
monkey
model
reminisc
find
publish
team
research
india
england
unit
state
work
madra
india
patient
hemorrhag
smallpox
also
highlevel
viremia
variola
exampl
concern
regard
hemorrhag
smallpox
clue
weapon
viru
late
inform
made
public
russian
newspap
west
regard
previous
unreport
smallpox
outbreak
involv
patient
aralsk
kazakhstan
former
soviet
union
fact
patient
diagnos
hemorrhag
smallpox
rais
possibl
clue
one
investig
virul
smallpox
viru
develop
test
time
near
aralsk
vozrozhdeniy
island
aral
sea
soviet
militari
henderson
doubt
interpret
point
one
person
ostens
infect
aerosol
actual
mild
case
case
result
secondari
transmiss
three
subsequ
manifest
hemorrhag
smallpox
transmit
infect
other
would
consist
rao
thesi
caus
hemorrhag
smallpox
relat
host
respons
rather
intrins
charact
viru
strain
rao
report
largest
seri
hemorrhag
smallpox
case
although
earlier
clinician
osler
textbook
medicin
recogn
two
type
hemorrhag
smallpox
rapidli
fatal
black
smallpox
later
pustular
form
detail
descript
clinic
epidemiolog
aspect
diseas
given
rao
publish
paper
describ
detail
hemorrhag
case
seen
repres
total
smallpox
case
smallpox
monograph
rao
review
patient
hemorrhag
smallpox
begin
thu
partial
overlap
earlier
seri
total
case
hemorrhag
smallpox
approxim
total
smallpox
case
seen
year
work
india
rao
report
case
hemorrhag
smallpox
even
one
transmit
hemorrhag
smallpox
anoth
person
suggest
host
respons
rather
viru
strain
critic
variabl
observ
rao
also
use
counter
argument
advanc
sarkar
mitra
hemorrhag
smallpox
patient
virul
viru
patient
confluent
discret
smallpox
work
calcutta
isol
variola
viru
patient
compar
hemorrhag
smallpox
confluent
smallpox
discret
smallpox
use
four
method
assess
virul
least
mortal
chick
embryo
least
mortal
infant
mice
histopatholog
pock
chorioallanto
membran
cam
least
pockform
unit
pfu
per
gram
liver
infect
chick
embryo
four
method
use
part
standard
method
assay
virul
variola
viru
posit
result
lead
classifi
virul
found
four
assay
hemorrhag
smallpox
case
compar
confluent
case
discretetyp
smallpox
case
virolog
mechan
find
never
report
one
methodolog
differ
albeit
uncertain
signific
variola
viru
hemorrhag
smallpox
case
isol
venou
blood
wherea
confluent
discret
case
isol
vesicular
pustular
fluid
studi
replic
restudi
salient
clinic
point
rao
hemorrhag
smallpox
patient
distinguish
earli
late
form
hemorrhag
smallpox
earli
form
patient
present
fever
sever
prodrom
symptom
includ
excruci
backach
sever
headach
hemorrhag
mucou
membran
skin
describ
velveti
touch
colour
death
occur
patient
averag
day
later
classic
smallpox
skin
lesion
never
develop
import
point
current
cdc
algorithm
evalu
rash
would
like
miss
patient
earli
hemorrhag
smallpox
lack
acut
gener
vesicular
pustular
rash
one
major
criteria
cdc
algorithm
tabl
potenti
diagnost
clue
even
atyp
form
smallpox
would
still
recogn
autopsi
rao
descript
late
hemorrhag
smallpox
base
remain
total
hemorrhag
smallpox
patient
start
febril
prodrom
may
may
sever
rash
actual
develop
papulovesicular
stage
averag
time
death
occur
case
day
consider
longer
day
found
earli
hemorrhag
smallpox
form
earli
late
form
pregnant
women
especi
vulner
hemorrhag
smallpox
strike
earli
form
patient
pregnant
women
compar
patient
late
form
earli
late
form
death
occur
despit
past
success
vaccin
least
recent
howev
vaccin
use
india
rao
studi
variabl
qualiti
appar
vaccin
scar
could
caus
trauma
skin
rotari
lancet
use
even
smallpox
vaccin
impot
illustr
histor
review
devic
tool
use
administ
smallpox
vaccin
provid
baxbi
visual
strike
review
emphas
bifurc
needl
fig
success
use
smallpox
global
erad
program
becam
avail
late
increas
hormon
level
associ
pregnanc
consid
rao
research
contribut
predisposit
high
case
fatal
rate
pregnant
women
hemorrhag
smallpox
rao
colleagu
india
report
extens
clinic
experi
smallpox
pregnanc
total
pregnant
women
also
compar
detail
consecut
pregnant
women
admit
period
comparison
group
nonpregn
women
men
multipl
find
includ
highest
risk
prematur
termin
pregnanc
occur
woman
infect
variola
earli
late
month
pregnanc
incid
hemorrhag
smallpox
much
higher
pregnant
women
nonpregn
women
men
specif
manifest
hemorrhag
smallpox
report
lowest
first
trimest
increas
peak
sixth
month
declin
seventh
eighth
month
rise
end
pregnanc
monograph
rao
summar
result
experi
publish
indian
journal
medic
research
use
monkey
model
defin
pathogenesi
smallpox
pregnanc
immunocompromis
host
exampl
administ
corticosteroid
cortison
prior
infect
variola
conclud
thu
cortison
shown
enhanc
diseas
variola
monkey
adequ
dose
cortison
variol
produc
fatal
form
smallpox
associ
intern
well
extern
hemorrhag
pregnant
monkey
cortisonis
monkey
react
smallpox
infect
way
pregnant
woman
smallpox
mechan
cortison
enhanc
diseas
still
vagu
monkey
use
experiment
variola
infect
studi
indian
bonnet
monkey
macacu
radiata
kg
weight
caught
around
madra
one
monkey
pregnant
fourth
egg
passag
variola
viru
suspens
deriv
vesicular
fluid
patient
smallpox
use
infect
monkey
variol
abdomen
use
tuberculin
syring
inject
variola
suspens
intraderm
total
monkey
variol
also
receiv
vari
dose
cortison
infect
other
receiv
placebo
rather
cortison
twelv
sixteen
cortison
anim
die
smallpox
wherea
control
monkey
die
cortison
monkey
develop
vari
degre
gener
smallpox
rash
control
anim
albeit
less
extens
compar
time
cours
viremia
group
show
higher
percentag
cortison
anim
virem
day
infect
autopsi
cortison
monkey
die
reveal
macroscop
petechi
hemorrhag
lung
gastrointestin
mucos
membran
variola
found
viscera
multipl
cortison
anim
autopsi
viru
found
singl
control
anim
sacrif
pregnant
monkey
receiv
cortison
abort
sixth
day
variol
die
twelfth
day
extens
hemorrhag
lung
intestin
mucou
membran
autopsi
unknown
reason
viral
infect
except
lassa
fever
viru
hepat
e
increas
case
fatal
rate
pregnant
women
smallpox
whether
immunolog
paradigm
describ
pregnanc
increas
type
cytokin
decreas
type
cytokin
play
etiolog
role
hemorrhag
smallpox
uncertain
interestingli
progesteron
hormon
elev
pregnanc
report
increas
product
tcell
includ
normal
produc
cytokin
specul
analog
pregnanc
increas
risk
sever
smallpox
exist
recent
experi
mousepox
engin
express
inhibit
cytotox
tcell
produc
caus
virul
diseas
overcom
protect
effect
prior
mousepox
vaccin
octob
director
dr
gro
harlem
brundtland
state
want
emphas
outbreak
smallpox
detect
countri
consid
intern
emerg
help
countri
pool
avail
resourc
contain
diseas
rapidli
effect
possibl
continu
provid
intern
support
effort
relat
smallpox
detect
vaccin
includ
provis
educ
resourc
websit
share
result
annual
sanction
research
variola
viru
russia
unit
state
worldwid
provid
support
surveil
network
smallpox
outbreak
via
global
outbreak
alert
respons
network
goarn
prepar
possibl
smallpox
viru
releas
potenti
bioterrorist
event
initi
number
nation
plan
effort
involv
us
scientist
public
health
offici
politician
regulatori
offici
other
provid
regular
updat
smallpox
smallpox
vaccin
sinc
updat
includ
address
smallpox
global
public
health
emerg
even
one
case
occur
post
websit
photograph
smallpox
smallpox
vaccin
respons
includ
comparison
chickenpox
fig
updat
review
risk
pose
biolog
weapon
post
annual
laboratori
research
variola
viru
russia
unit
state
work
includ
pathogenesi
variola
infect
serolog
assay
pcrbase
diagnost
assay
anim
model
develop
studi
new
vaccin
antivir
drug
includ
tyrosin
kinas
inhibitor
antileukemia
drug
gleevac
wwwwhointcsrdiseasesmallpoxresearchen
israel
first
nation
begin
smallpox
vaccin
follow
anthrax
attack
unit
state
initi
phase
vaccin
carri
septemb
januari
first
respond
includ
hcw
vaccin
use
lister
strain
vaccinia
studi
subset
vaccine
previous
vaccin
show
vaccine
success
clinic
take
understand
vaccin
titer
much
lower
intern
standard
septemb
multin
global
health
secur
initi
ghsi
workshop
held
paul
ehrlich
institut
langen
germani
best
practic
vaccin
product
smallpox
potenti
pathogen
nation
region
inform
current
project
smallpox
vaccin
antivir
drug
present
scientist
japan
pan
american
health
organ
european
union
germani
franc
belgium
unit
state
other
us
food
drug
administr
fda
regulatori
requir
licensur
smallpox
vaccin
present
septemb
intern
command
post
exercis
name
global
mercuri
involv
scenario
multipl
terrorist
inocul
smallpox
travel
differ
part
world
conduct
canada
mexico
japan
itali
germani
franc
uk
unit
state
european
commiss
involv
realtim
exercis
detail
post
health
canada
websit
wwwhcscgccaenglishmediaissuesglobalmercurysummaryhtml
six
recommend
result
exercis
one
import
recognit
need
strengthen
alreadi
exist
nation
smallpox
respons
plan
greater
elabor
intern
compon
also
found
form
commun
maintain
adequ
realtim
manner
exercis
across
multipl
contin
nation
better
commun
infrastructur
improv
inform
manag
process
train
public
health
personnel
need
octob
intern
confer
held
geneva
past
smallpox
weapon
develop
current
threat
smallpox
vaccin
issu
copi
slide
present
post
onlin
wwwsmallpoxbiosecurityorg
partli
special
supplement
intern
journal
infecti
diseas
novemb
symposium
smallpox
smallpox
vaccin
held
hong
kong
sponsor
health
depart
hong
kong
one
us
dl
present
preevent
postev
smallpox
vaccin
scenario
discuss
lesson
learn
us
smallpox
vaccin
program
also
present
smallpox
prepared
program
hong
kong
alreadi
initi
prior
onset
sar
epidem
februari
issu
regard
share
smallpox
vaccin
need
help
control
intern
outbreak
also
discuss
decemb
uk
post
depart
health
websit
wwwdhgovuk
updat
smallpox
plan
valuabl
refer
document
appendic
larg
amount
detail
regard
common
critic
public
health
issu
would
occur
anywher
world
smallpox
outbreak
occur
particularli
help
highli
specif
algorithm
manag
initi
suspect
smallpox
case
depend
first
locat
separ
algorithm
given
suspect
case
home
emerg
depart
accid
emerg
gener
hospit
ward
surgeri
clinic
intens
care
unit
infecti
diseas
unit
port
health
control
unit
addit
detail
recommend
provid
vaccin
strategi
level
alert
exampl
smallpox
report
outsid
uk
alert
level
uk
alert
level
notabl
uk
plan
includ
specif
smallpox
outbreak
alert
level
largescal
outbreak
occur
contain
ring
vaccin
alert
level
wherea
surveil
contain
sometim
refer
ring
vaccin
recommend
uk
alert
level
done
cdc
mass
vaccin
consid
alert
level
depend
circumst
riskbenefit
analys
time
januari
smallpox
tabletop
exercis
name
atlant
storm
carri
describ
onlin
wwwupmcbiosecurityorg
hypothet
scenario
terrorist
releas
smallpox
viru
six
target
area
via
commerci
avail
dri
powder
dispens
hidden
backpack
target
includ
crowd
public
site
frankfurt
istanbul
rotterdam
warsaw
lo
angel
new
york
citi
two
observ
atlant
storm
exercis
deserv
particular
notic
respect
avail
vaccin
nation
stock
smallpox
vaccin
countri
vaccin
believ
would
need
citizen
total
global
stockpil
vaccin
amount
million
dose
rel
global
popul
stockpil
consist
million
dose
five
vaccin
product
laboratori
emerg
condit
output
would
much
million
dose
per
month
present
place
mechan
decid
prioriti
global
alloc
vaccin
case
emerg
present
forum
wherein
differ
countri
case
emerg
could
work
effect
common
polici
respect
restrict
travel
harmon
nation
polici
mobil
nonhealth
resourc
sum
need
work
collabor
intern
basi
includ
discuss
share
smallpox
vaccin
suppli
prior
smallpox
outbreak
critic
prepar
best
could
rapidli
becom
global
public
health
emerg
event
cdc
develop
algorithm
evalu
suspect
patient
smallpox
focus
patient
fever
follow
gener
vesicular
pustular
rash
month
januari
june
cdc
consult
patient
suspect
smallpox
part
algorithm
major
minor
criteria
develop
tabl
high
medium
low
risk
patient
identifi
decreas
number
falseposit
laboratori
test
variola
viru
person
classifi
algorithm
highrisk
smallpox
underw
test
variola
highrisk
case
undergo
laboratori
test
anoth
diseas
laboratori
test
complet
variola
viru
accord
algorithm
patient
gener
vesicular
pustular
rash
fever
immedi
place
airborn
contact
precaut
infect
control
team
notifi
cdc
investig
report
period
none
case
suspect
smallpox
met
criteria
highrisk
eight
classifi
moderaterisk
lowrisk
despit
classifi
highrisk
one
patient
variola
test
perform
result
neg
final
diagnosi
common
diagnosi
varicella
eight
moderaterisk
case
five
due
varicella
one
due
drug
reaction
one
due
erythema
multiform
one
due
eczema
seven
occas
hospit
emerg
depart
closur
divers
occur
use
algorithm
facilit
prompt
revers
closur
divers
cdc
author
ad
import
caveat
algorithm
design
detect
sever
atyp
form
smallpox
flattyp
hemorrhag
type
color
poster
onlin
version
cdc
smallpox
algorithm
rapid
interact
individu
patient
classif
option
avail
via
cdc
websit
wwwbtcdcgovagentsmallpoxdiagnosispdfspoxposterfullpdf
cdc
websit
smallpox
wwwbtcdcgovagentsmallpoxindexasp
contain
extens
inform
smallpox
smallpox
vaccin
contact
trace
quarantin
isol
criteria
contagi
facil
smallpox
patient
could
hospit
otherwis
cohort
care
vig
cidofovir
multipl
relat
issu
sever
hundr
photograph
illustr
key
point
smallpox
smallpox
vaccin
avail
eg
fig
wwwbtcdcgovagentsmallpoxsmallpoximag
cdc
sought
outsid
guidanc
institut
medicin
iom
smallpox
issu
report
least
six
meet
submit
cdc
director
institut
medicin
committe
smallpox
vaccin
program
implement
six
iom
report
found
onlin
wwwiomedureportasp
id
committe
recommend
assess
trace
cours
focus
smallpox
smallpox
vaccin
includ
activ
surveil
advers
event
recommend
smallpox
prepared
incorpor
gener
allhazard
emerg
prepared
program
committe
emphas
smallpox
vaccin
one
aspect
prepared
smallpox
detail
prepared
plan
smallpox
public
health
emerg
written
critiqu
assess
via
train
exercis
smallpox
vaccin
develop
divid
three
gener
vaccin
first
gener
vaccin
use
vaccinia
viru
grown
skin
calf
subsequ
purifi
harvest
unit
state
vaccin
lyophil
freezedri
prepar
produc
reconstitut
use
replac
secondgener
vaccin
acam
see
anoth
firstgener
smallpox
vaccin
avail
unit
state
store
frozen
rather
lyophil
approxim
million
dose
provid
us
govern
aventi
pasteur
dilut
studi
adult
use
dilut
vaccin
show
equival
vaccin
take
rate
vaccin
undilut
dilut
dilut
field
condit
lower
take
rate
would
expect
thu
vaccin
recommend
use
dilut
emerg
circumst
socal
secondgener
smallpox
vaccin
grown
tissu
cell
cultur
vaccinia
viru
strain
plaqu
purifi
strain
deriv
use
prepar
anim
lymph
vaccin
frequenc
advers
event
expect
compar
least
two
differ
tissu
cell
cultur
vaccin
type
enter
clinic
trial
acam
grown
african
green
monkey
kidney
vero
cell
made
acambi
partnership
baxter
chick
embryo
cellcultur
smallpox
vaccin
made
bavarian
nordic
danish
compani
acam
vaccin
use
vaccinia
viru
deriv
new
york
citi
board
health
seed
strain
bavarian
nordic
use
listerderiv
vaccinia
strain
septemb
fda
announc
licensur
secondgener
smallpox
vaccin
acam
includ
medic
guid
sixpag
medic
guid
includ
inform
regard
possibl
side
effect
vaccin
medic
condit
predispos
side
effect
care
vaccin
site
avoid
get
vaccin
acambi
produc
suppli
us
stockpil
million
dose
new
vaccin
initi
phase
clinic
trial
acam
demonstr
compar
safeti
immunogen
dryvax
firstgener
vaccin
larger
phase
iii
trial
requir
licensur
patient
myopericard
diagnos
dryvax
comparatorcontrol
vaccin
recipi
tissu
cultur
vaccin
recipi
symptom
mild
transient
sequela
detect
thirdgener
smallpox
vaccin
includ
made
attenu
vaccinia
viru
strain
mva
recent
dnabas
vaccin
use
select
dna
segment
vaccinia
viru
rather
entir
viru
central
concept
behind
thirdgener
vaccin
increas
safeti
profil
use
attenu
vaccinia
virus
dnabas
vaccin
rather
nonattenu
live
replic
vaccinia
viru
use
first
secondgener
vaccin
dna
subunit
vaccin
approach
report
hooper
et
al
demonstr
rhesu
macaqu
monkey
protect
sever
diseas
normal
lethal
challeng
monkeypox
viru
administ
mva
nonrepl
attenu
vaccinia
strain
develop
germani
use
prior
vaccin
tradit
lister
lymph
vaccin
strain
expect
mva
might
protect
vaccin
complic
caus
lister
strain
test
efficaci
smallpox
outbreak
immunocompet
monkey
given
either
two
dose
mva
one
dose
mva
follow
one
dose
dryvax
success
protect
intraven
infect
monkeypox
orthopoxviru
close
relat
smallpox
precis
vaccineassoci
correl
protect
unknown
author
found
antibodi
bind
neutral
titer
well
vacciniavirusspecif
produc
tcell
equival
higher
immun
monkey
compar
receiv
singl
dose
standard
lymph
vaccin
dryvax
extend
lethal
monkeypox
viru
challeng
immunocompromis
monkey
specif
macaqu
infect
aidscaus
siv
fail
show
vaccin
protect
anim
becom
sever
immunodefici
tcell
count
cellsul
june
us
govern
announc
purchas
approxim
million
dose
mva
stockpil
event
smallpox
bioterrorist
attack
use
twodos
regimen
stockpil
would
suffici
vaccin
estim
million
immunocompromis
peopl
usa
anoth
attenu
vaccinia
viru
thirdgener
vaccin
smallpox
vaccin
develop
japan
repeat
lowtemperatur
tissu
cell
cultur
passag
lister
strain
vaccinia
licens
use
japan
vaccin
replic
strain
cultur
primari
rabbit
kidney
cell
cultur
administ
japanes
children
produc
smaller
primari
vaccin
lesion
fewer
secondari
symptom
sign
dryvax
wwwwhointentitycsrdiseasesmallpoxlancegordonpdf
vig
produc
test
intraven
formul
rather
intramuscular
form
tradit
use
studi
use
ivvig
show
compar
im
product
ivvig
safe
well
toler
yield
higher
peak
level
sooner
day
seen
administr
lyophil
imvig
liquid
form
ivvig
found
compar
advers
reaction
rate
lyophil
formul
fda
licens
intraven
formul
vig
vigiv
dynport
vaccin
compani
llc
februari
histor
review
vig
use
efficaci
hopkin
lane
found
random
control
trial
vig
prior
fda
licensur
thu
recommend
use
vig
base
observ
data
vig
believ
prevent
decreas
vaccinia
complic
person
increas
risk
eczema
atop
dermat
studi
perform
dutch
militari
recruit
receiv
vig
smallpox
vaccin
use
european
strain
vaccinia
compar
number
receiv
placebo
vaccin
three
recruit
develop
enceph
group
receiv
vig
compar
control
signific
observ
puzzl
believ
pathogenesi
postvaccin
enceph
autoimmun
respons
rather
result
vaccinia
infect
brain
antivir
drug
yet
licens
fda
prevent
treatment
smallpox
monkeypox
vaccinia
viru
diseas
june
iom
conven
committe
review
discuss
possibl
develop
smallpox
antivir
smallpox
drug
sever
new
candid
antivir
drug
strategi
review
seven
recommend
regard
futur
initi
made
includ
expans
broad
intern
collabor
central
resourc
pharmaceut
compani
engag
train
new
cohort
investig
format
highlevel
oversight
panel
much
like
aid
vaccin
research
work
group
would
report
director
nih
cdc
feder
agenc
antivir
drug
cidofovir
extens
studi
possibl
use
treatment
prevent
orthopoxviru
infect
well
dna
virus
drug
licens
fda
treatment
cytomegaloviru
cmv
immunocompromis
patient
hivaid
recent
literatur
cidofovir
poxviru
infect
includ
investig
oral
formul
publish
bray
colleagu
possibl
role
cidofovir
prophylaxi
limit
prevent
infect
experiment
anim
presum
man
given
time
actual
infect
sinc
vaccin
serv
protect
even
given
sever
day
infect
cidofovir
offer
advantag
shown
effect
anim
studi
infect
establish
current
iv
form
cidofovir
highli
toxic
includ
renal
toxic
renal
shut
occur
administr
singl
dose
oral
formul
develop
reason
nearcomplet
cessat
smallpox
vaccin
includ
follow
lack
adequ
liabil
compens
protect
place
time
vaccin
program
began
tabl
potenti
mandat
time
away
clinic
work
furlough
vaccin
scab
fell
perceiv
health
risk
transmit
vaccinia
colleagu
patient
health
concern
candid
vaccine
insuffici
definit
threat
smallpox
use
bioterror
weapon
hospit
legal
concern
compet
oblig
prioriti
resourc
depart
health
unanticip
myopericard
case
nonfat
small
number
cardiac
death
tempor
causal
link
smallpox
vaccin
media
coverag
given
lack
weapon
mass
destruct
found
iraq
march
invas
lack
addit
terror
attack
prepar
potenti
bioterror
agent
smallpox
also
prepar
emerg
diseas
sar
similar
see
tabl
pandem
influenza
anoth
new
respiratori
infecti
diseas
term
similar
transmiss
need
person
protect
equip
ppe
hospit
prepared
public
health
respons
accordingli
cours
month
start
end
washington
hospit
center
undertook
formal
fittest
program
respir
success
train
clinic
nonclin
worker
appropri
use
respir
better
prepar
hospit
care
patient
spectrum
droplet
aerosoltransmit
respiratori
diseas
includ
smallpox
viral
hemorrhag
fever
pneumon
plagu
recent
emerg
diseas
sar
avian
pandem
influenza
nipah
viru
tradit
threat
tuberculosi
measl
similar
smallpox
hospit
outbreak
mesched
germani
sar
coronaviru
report
transmit
least
occas
via
droplet
nuclei
aerosol
amoy
garden
residenti
complex
outbreak
citywid
level
work
dc
depart
health
spring
one
us
dl
initi
purchas
stockpil
larg
number
respir
surgic
mask
million
experi
nation
hard
hit
sar
epidem
acut
shortag
respir
surgic
mask
must
anticip
would
need
avail
immedi
follow
releas
smallpox
certain
hemorrhag
fever
pandem
influenza
sar
bioterrorist
emerg
pathogen
prepar
smallpox
prepar
mani
public
health
threat
face
today
face
futur
integr
smallpox
prepared
measur
broader
public
health
prepared
local
region
nation
one
primari
recommend
committe
smallpox
vaccin
program
implement
iom
nation
academi
scienc
explicit
comparison
smallpox
pandem
influenza
sar
made
august
us
draft
pandem
influenza
plan
prepar
optim
smallpox
unit
state
requir
prepar
global
basi
prevent
return
smallpox
wherea
intensifi
global
program
requir
erad
smallpox
human
popul
today
futur
intensifi
longterm
global
program
watch
prepar
respons
requir
prevent
smallpox
reestablish
endem
diseas
outbreak
monkeypox
occur
first
time
unit
state
outbreak
compon
involv
human
began
may
confirm
laboratori
test
cdc
earli
june
monkeypox
known
anim
sinc
human
sinc
orthopoxviru
relat
variola
vaccinia
virus
monkeypox
never
previous
report
outsid
africa
secondari
attack
rate
low
extend
beyond
four
gener
make
diseas
low
epidem
potenti
two
clade
found
one
west
african
one
congoles
unlik
smallpox
monkeypox
zoonosi
africa
us
outbreak
link
infect
anim
gener
clinic
manifest
monkeypox
includ
fever
sequenti
appear
resolut
skin
lesion
well
incub
period
similar
smallpox
one
specif
find
distinguish
monkeypox
smallpox
lymphadenopathi
especi
cervic
inguin
region
patient
monkeypox
chickenpox
vzv
anoth
diseas
routin
consid
differenti
diagnosi
monkeypox
inde
rimoin
colleagu
unit
state
democrat
republ
congo
drc
report
laboratori
studi
patient
drc
suspect
monkeypox
confirm
monkeypox
wherea
varicellazost
viru
vzv
one
infect
virus
potenti
monkeypox
emerg
diseas
problem
discuss
breman
relat
increas
contact
human
anim
endem
area
wane
vacciniainduc
immun
addit
us
outbreak
inger
damon
cdc
colleagu
medecin
san
frontier
msf
report
laboratori
confirm
monkeypox
viru
first
time
sudan
identifi
monkeypox
viru
isol
novemb
mother
young
child
southern
sudan
clinic
suspect
monkeypox
genet
sequenc
isol
consist
clade
congo
basin
epidemiolog
studi
sudan
msf
reveal
small
cluster
selflimit
diseas
compat
monkeypox
occur
wide
spread
within
commun
death
report
among
patient
suspect
case
endem
natur
host
monkeypox
known
certainti
serolog
evid
orthopoxviru
infect
presum
due
monkeypox
found
rodent
africa
includ
gambian
giant
pouch
rat
rope
squirrel
first
outbreak
unit
state
trace
import
wild
rodent
accra
ghana
west
africa
arriv
texa
april
subsequ
test
anim
cdc
reveal
pcr
viru
isol
demonstr
least
one
gambian
giant
rat
three
dormic
two
rope
squirrel
posit
monkeypox
gambian
giant
rat
hous
prairi
dog
illinoi
pet
distributor
prairi
dog
found
suscept
monkeypox
close
contact
human
infect
pet
includ
prairi
dog
result
monkeypox
infect
least
person
initi
studi
pathogenesi
monkeypox
north
american
prairi
dog
publish
laboratoryconfirm
infect
unit
state
mild
manifest
fever
rash
limit
number
lesion
patient
confirm
monkeypox
illinoi
indiana
kansa
missouri
wisconsin
occup
exposur
prairi
monkeypox
infect
veterinari
facil
wisconsin
report
detail
june
combin
order
cdc
fda
prohibit
import
african
rodent
sale
transport
unit
state
six
genera
african
rodent
us
prairi
dog
patient
direct
exposur
infect
anim
evid
persontoperson
transmiss
occur
onethird
patient
known
histori
least
one
smallpox
vaccin
distant
past
none
patient
die
two
children
becam
serious
ill
eventu
recov
one
child
respiratori
difficulti
mark
cervic
adenopathi
pharyng
lesion
requir
mechan
ventil
sever
enceph
occur
one
previous
healthi
whose
famili
purchas
one
monkeypoxinfect
prairi
dog
two
adult
famili
mild
monkeypox
diseas
one
adult
vaccin
child
minim
symptom
skin
lesion
three
member
famili
one
skin
lesion
palm
child
enceph
also
cervic
lymphadenopathi
uncommon
find
smallpox
develop
seizur
place
ventil
cerebrospin
fluid
igm
posit
orthopoxviru
pcr
cultur
csf
neg
eventu
made
full
recoveri
smallpox
vacciniaassoci
enceph
neither
vig
cidofovir
recommend
treatment
monkeypox
enceph
neither
agent
given
patient
june
cdc
issu
interim
guidanc
regard
use
smallpox
vaccin
vig
antivir
drug
cidofovir
prevent
therapi
monkeypox
outbreak
regard
smallpox
vaccin
vaccinia
viru
known
studi
africa
confer
protect
monkeypox
given
exposur
monkeypox
unlik
smallpox
diseas
data
exist
efficaci
give
smallpox
vaccin
exposur
monkeypox
term
prevent
decreas
sever
ill
although
believ
would
effect
accordingli
cdc
offer
guidanc
use
smallpox
vaccin
differ
group
risk
exposur
monkeypox
hcw
care
proven
suspect
case
monkeypox
veterinarian
expos
anim
prairi
dog
monkeypox
advis
receiv
smallpox
vaccin
within
day
initi
exposur
consid
vaccin
week
recent
exposur
cdc
also
advis
even
previous
vaccin
hcw
worker
continu
use
ppe
includ
fittest
respir
follow
airborn
contact
standard
infect
control
precaut
hcw
could
assign
care
patient
monkeypox
futur
advis
receiv
smallpox
vaccin
confirm
take
care
patient
done
vaccin
care
patient
indic
similar
smallpox
vaccin
close
contact
monkeypox
patient
address
cdc
work
definit
close
contact
appli
monkeypox
use
smallpox
medic
contraind
smallpox
vaccin
maintain
even
person
close
intim
contact
symptomat
laboratoryconfirm
case
monkeypox
within
prior
week
person
tcell
immunodefici
advis
vaccin
includ
aidsdefin
tcell
count
solid
bone
marrow
transplant
recipi
person
receiv
highdos
immunosuppress
medic
hematolog
malign
congenit
tcell
defect
otherwis
neither
pregnanc
age
histori
activ
eczema
consid
contraind
smallpox
vaccin
vig
recommend
either
prophylaxi
treatment
monkeypox
patient
data
exist
role
either
set
consider
cidofovir
given
last
resort
clinic
set
lifethreaten
monkeypox
infect
prophylaxi
patholog
find
clinic
present
monkeypox
report
two
prairi
dog
infect
outbreak
unit
state
evid
viral
replic
found
lung
necrot
bronchopneumonia
found
ulcer
lesion
tongu
potenti
transmiss
monkeypox
mucocutan
exposur
respiratori
rout
evid
given
suscept
prairi
dog
sever
monkeypox
diseas
anim
could
serv
model
research
antivir
drug
new
vaccin
develop
monkeypox
evid
date
monkeypox
becom
endem
us
anim
prairi
dog
occur
yersinia
pesti
plagu
emerg
california
earli
follow
spread
china
guangdong
provinc
hong
kong
san
francisco
